Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Reversing inflammation in fluid near brain's cortex may provide solution to Parkinson's disease

Reversing inflammation in the fluid surrounding the brain's cortex may provide a solution to the complex riddle of Parkinson's, according to researchers who have found a link between pro-inflammatory biomarkers and the severity of symptoms such as fatigue, depression and anxiety in patients with the chronic disease.

29 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

SDSU researchers develop new device to accurately diagnose concussions from sidelines

In the United States there are millions of sports related concussions each year, but many go undiagnosed because for some athletes, the fear of being benched trumps the fear of permanent brain damage, and there is no objective test available to accurately diagnose concussions on the sidelines.

28 Aug 2013

Novel Parkinson’S Target Uncovered

Researchers from Johns Hopkins and the National Cancer Institute (NCI) highlighted a novel mechanism underlying Parkinson's disease while simultaneously putting to rest a previously held theory regarding progression of the disorder. They also identified a compound that alleviates the disease's symptoms in mice.

27 Aug 2013

Scientists finds link between protein phosphorylation and Parkinson's disease

Clues left at the scene of the crime don't always point to the guilty party, as EPFL researchers investigating Parkinson's disease have discovered. It is generally accepted that the disease is aggravated when a specific protein is transformed by an enzyme.

27 Aug 2013

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease.

27 Aug 2013

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer's disease, Parkinson's disease and other brain-damaging disorders.

26 Aug 2013

Researchers identify compound that eases symptoms of Parkinson's disease

Researchers at Johns Hopkins and elsewhere have brought new clarity to the picture of what goes awry in the brain during Parkinson's disease and identified a compound that eases the disease's symptoms in mice.

26 Aug 2013

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

23 Aug 2013

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

New research suggests that chronic traumatic encephalopathy, a brain disease associated with repeat brain trauma including concussions in athletes, may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities.

22 Aug 2013

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Overnight flights across the Atlantic, graveyard shifts, stress-induced insomnia are all prime culprits in keeping us from getting a good night's sleep. Thanks to new research from McGill University and Concordia University, however, these common sleep disturbances may one day be put to bed.

22 Aug 2013

LBDA creates two LBD symptom checklists for physicians and patients

The Lewy Body Dementia Association announced today the launch of new resources for physicians and their patients. LBDA created two new LBD symptom checklists; an abbreviated checklist to assist in the reporting of LBD diagnostic symptoms and a more comprehensive checklist to help people already diagnosed with LBD or their caregivers to report new or concerning LBD symptoms as the disease progresses.

22 Aug 2013

Pilots who fly at high altitudes may be at increased risk for brain lesions

A new study suggests that pilots who fly at high altitudes may be at an increased risk for brain lesions. The study is published in the August 20, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.

20 Aug 2013

UCSF study shows potential for new treatment strategy for Parkinson’s disease

UC San Francisco scientists working in the lab used a chemical found in an anti-wrinkle cream to prevent the death of nerve cells damaged by mutations that cause an inherited form of Parkinson-s disease.

17 Aug 2013

Neurologist writes "explosion of new and innovative" therapies for neurologic conditions

There has been an "explosion of new and innovative" therapies for neurologic conditions such as stroke, epilepsy, Parkinson disease and multiple sclerosis, Loyola University Medical Center neurologist Dr. Jose Biller writes in the August issue of the journal Neurologic Clinics.

16 Aug 2013

Kinetin stops the effects of Parkinson's disease on brain cells, say scientists

The active ingredient in an over-the-counter skin cream might do more than prevent wrinkles. Scientists have discovered that the drug, called kinetin, also slows or stops the effects of Parkinson's disease on brain cells.

16 Aug 2013

X-linked methyl-CpG protein may be potential target for treatment of Parkinson's

X-linked methyl-CpG binding protein 2 plays important role in the regulation of neuronal development, proliferation and maturation, and synaptic regeneration and apoptosis.

13 Aug 2013

Durin receives grant to expand novel blood test that can detect Parkinson's

The Michael J. Fox Foundation for Parkinson's Research has awarded Durin Technologies, Inc., a grant of $351,200 to expand the development of Durin's novel blood test that can detect the presence of Parkinson's disease.

13 Aug 2013

Simple tests to recognize ability of famous people may help doctors identify early dementia

A new study suggests that simple tests that measure the ability to recognize and name famous people such as Albert Einstein, Bill Gates or Oprah Winfrey may help doctors identify early dementia in those 40 to 65 years of age.

13 Aug 2013

Researchers suggest neural stem cells may regenerate after anti-cancer treatment

Scientists have long believed that healthy brain cells, once damaged by radiation designed to kill brain tumors, cannot regenerate. But new Johns Hopkins research in mice suggests that neural stem cells, the body's source of new brain cells, are resistant to radiation, and can be roused from a hibernation-like state to reproduce and generate new cells able to migrate, replace injured cells and potentially restore lost function.

13 Aug 2013

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Reversing inflammation in fluid near brain's cortex may provide solution to Parkinson's disease

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

SDSU researchers develop new device to accurately diagnose concussions from sidelines

Novel Parkinson’S Target Uncovered

Scientists finds link between protein phosphorylation and Parkinson's disease

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Researchers identify compound that eases symptoms of Parkinson's disease

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

LBDA creates two LBD symptom checklists for physicians and patients

Pilots who fly at high altitudes may be at increased risk for brain lesions

UCSF study shows potential for new treatment strategy for Parkinson’s disease

Neurologist writes "explosion of new and innovative" therapies for neurologic conditions

Kinetin stops the effects of Parkinson's disease on brain cells, say scientists

X-linked methyl-CpG protein may be potential target for treatment of Parkinson's

Durin receives grant to expand novel blood test that can detect Parkinson's

Simple tests to recognize ability of famous people may help doctors identify early dementia

Researchers suggest neural stem cells may regenerate after anti-cancer treatment

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in